Annual Cash & Cash Equivalents
$31.36 M
-$26.35 M-45.66%
December 31, 2023
Summary
- As of February 8, 2025, VOR annual cash & cash equivalents is $31.36 million, with the most recent change of -$26.35 million (-45.66%) on December 31, 2023.
- During the last 3 years, VOR annual cash & cash equivalents has fallen by -$17.18 million (-35.39%).
- VOR annual cash & cash equivalents is now -73.82% below its all-time high of $119.80 million, reached on December 31, 2021.
Performance
VOR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$52.80 M
-$23.28 M-30.60%
September 30, 2024
Summary
- As of February 8, 2025, VOR quarterly cash and cash equivalents is $52.80 million, with the most recent change of -$23.28 million (-30.60%) on September 30, 2024.
- Over the past year, VOR quarterly cash and cash equivalents has increased by +$21.44 million (+68.36%).
- VOR quarterly cash and cash equivalents is now -79.89% below its all-time high of $262.57 million, reached on March 31, 2021.
Performance
VOR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VOR Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.7% | +68.4% |
| 3 y3 years | -35.4% | +68.4% |
| 5 y5 years | +3275.7% | +68.4% |
VOR Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.8% | at low | -55.9% | +68.4% |
| 5 y | 5-year | -73.8% | +385.0% | -79.9% | +716.5% |
| alltime | all time | -73.8% | +3275.7% | -79.9% | +716.5% |
Vor Biopharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $52.80 M(-30.6%) |
| Jun 2024 | - | $76.08 M(+69.2%) |
| Mar 2024 | - | $44.96 M(+43.4%) |
| Dec 2023 | $31.36 M(-45.7%) | $31.36 M(-30.4%) |
| Sep 2023 | - | $45.03 M(+39.8%) |
| Jun 2023 | - | $32.21 M(-24.1%) |
| Mar 2023 | - | $42.45 M(-26.4%) |
| Dec 2022 | $57.71 M | $57.71 M(-5.1%) |
| Sep 2022 | - | $60.83 M(-3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $62.95 M(-30.1%) |
| Mar 2022 | - | $90.04 M(-24.8%) |
| Dec 2021 | $119.80 M(+146.8%) | $119.80 M(-16.2%) |
| Sep 2021 | - | $143.03 M(-15.6%) |
| Jun 2021 | - | $169.52 M(-35.4%) |
| Mar 2021 | - | $262.57 M(+440.9%) |
| Dec 2020 | $48.54 M(+650.7%) | $48.54 M(-23.7%) |
| Sep 2020 | - | $63.60 M(+883.7%) |
| Dec 2019 | $6.47 M(+596.0%) | $6.47 M |
| Dec 2018 | $929.00 K | - |
FAQ
- What is Vor Biopharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Vor Biopharma?
- What is Vor Biopharma annual cash & cash equivalents year-on-year change?
- What is Vor Biopharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Vor Biopharma?
- What is Vor Biopharma quarterly cash and cash equivalents year-on-year change?
What is Vor Biopharma annual cash & cash equivalents?
The current annual cash & cash equivalents of VOR is $31.36 M
What is the all time high annual cash & cash equivalents for Vor Biopharma?
Vor Biopharma all-time high annual cash & cash equivalents is $119.80 M
What is Vor Biopharma annual cash & cash equivalents year-on-year change?
Over the past year, VOR annual cash & cash equivalents has changed by -$26.35 M (-45.66%)
What is Vor Biopharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VOR is $52.80 M
What is the all time high quarterly cash and cash equivalents for Vor Biopharma?
Vor Biopharma all-time high quarterly cash and cash equivalents is $262.57 M
What is Vor Biopharma quarterly cash and cash equivalents year-on-year change?
Over the past year, VOR quarterly cash and cash equivalents has changed by +$21.44 M (+68.36%)